Shots:

• Ozabax is a gamma-aminobutyric acid (GABA-ergic) agonist orally administered low dosage and is available as a 5mg/5 ml oral solution
• The efficacy of Ozobax is based on the bioavailability study evaluated in healthy adults in comparison with Baclofen oral tablets
• Metacel is also planning to launch Ozobax with pending plans. Ozobax has a warning of for its withdrawal can lead to neonatal withdrawal symptoms- drowsiness and sedation- poor tolerability in stroke patients- schizophrenia- or confusional states- and ovarian cysts

Click here to­ read full press release/ article | Ref: OptumRx | Image: Twitter